カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のソリフェナシンコハク酸塩製剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Solifenacin Succinate Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19636）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19636
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のソリフェナシンコハク酸塩製剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ソリフェナシンコハク酸塩製剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のソリフェナシンコハク酸塩製剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ソリフェナシンコハク酸塩製剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・5mg錠、10mg錠

用途別セグメントは次のように区分されます。
・病院、ドラッグストア

世界のソリフェナシンコハク酸塩製剤市場の主要な市場プレーヤーは以下のとおりです。
・Astellas Pharma、Teva、Ajanta Pharma、Aurobindo Pharma、Glenmark Pharmaceuticals、Qilu Pharmaceutical、Cipla、Jiangxi Boya Seehot Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ソリフェナシンコハク酸塩製剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なソリフェナシンコハク酸塩製剤メーカーの企業概要、2019年～2022年までのソリフェナシンコハク酸塩製剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なソリフェナシンコハク酸塩製剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ソリフェナシンコハク酸塩製剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのソリフェナシンコハク酸塩製剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのソリフェナシンコハク酸塩製剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびソリフェナシンコハク酸塩製剤の産業チェーンを掲載しています。
・第13、14、15章では、ソリフェナシンコハク酸塩製剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ソリフェナシンコハク酸塩製剤の概要
- 種類別分析（2017年vs2021年vs2028年）：5mg錠、10mg錠
- 用途別分析（2017年vs2021年vs2028年）：病院、ドラッグストア
- 世界のソリフェナシンコハク酸塩製剤市場規模・予測
- 世界のソリフェナシンコハク酸塩製剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Astellas Pharma、Teva、Ajanta Pharma、Aurobindo Pharma、Glenmark Pharmaceuticals、Qilu Pharmaceutical、Cipla、Jiangxi Boya Seehot Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：5mg錠、10mg錠
・用途別分析2017年-2028年：病院、ドラッグストア
・ソリフェナシンコハク酸塩製剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ソリフェナシンコハク酸塩製剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ソリフェナシンコハク酸塩製剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ソリフェナシンコハク酸塩製剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ソリフェナシンコハク酸塩製剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Solifenacin Succinate Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Solifenacin Succinate Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Solifenacin Succinate Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 5 mg Tablet segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Solifenacin Succinate Drug include Astellas Pharma, Teva, Ajanta Pharma, Aurobindo Pharma, and Glenmark Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Solifenacin Succinate Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5 mg Tablet
10 mg Tablet
Market segment by Application can be divided into
Hospital
Drug store
The key market players for global Solifenacin Succinate Drug market are listed below:
Astellas Pharma
Teva
Ajanta Pharma
Aurobindo Pharma
Glenmark Pharmaceuticals
Qilu Pharmaceutical
Cipla
Jiangxi Boya Seehot Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Solifenacin Succinate Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Solifenacin Succinate Drug, with price, sales, revenue and global market share of Solifenacin Succinate Drug from 2019 to 2022.
Chapter 3, the Solifenacin Succinate Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Solifenacin Succinate Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Solifenacin Succinate Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Solifenacin Succinate Drug.
Chapter 13, 14, and 15, to describe Solifenacin Succinate Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Solifenacin Succinate Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Solifenacin Succinate Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 5 mg Tablet
1.2.3 10 mg Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Solifenacin Succinate Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Solifenacin Succinate Drug Market Size & Forecast
1.4.1 Global Solifenacin Succinate Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Solifenacin Succinate Drug Sales in Volume (2017-2028)
1.4.3 Global Solifenacin Succinate Drug Price (2017-2028)
1.5 Global Solifenacin Succinate Drug Production Capacity Analysis
1.5.1 Global Solifenacin Succinate Drug Total Production Capacity (2017-2028)
1.5.2 Global Solifenacin Succinate Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Solifenacin Succinate Drug Market Drivers
1.6.2 Solifenacin Succinate Drug Market Restraints
1.6.3 Solifenacin Succinate Drug Trends Analysis
2 Manufacturers Profiles
2.1 Astellas Pharma
2.1.1 Astellas Pharma Details
2.1.2 Astellas Pharma Major Business
2.1.3 Astellas Pharma Solifenacin Succinate Drug Product and Services
2.1.4 Astellas Pharma Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Solifenacin Succinate Drug Product and Services
2.2.4 Teva Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Ajanta Pharma
2.3.1 Ajanta Pharma Details
2.3.2 Ajanta Pharma Major Business
2.3.3 Ajanta Pharma Solifenacin Succinate Drug Product and Services
2.3.4 Ajanta Pharma Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Aurobindo Pharma
2.4.1 Aurobindo Pharma Details
2.4.2 Aurobindo Pharma Major Business
2.4.3 Aurobindo Pharma Solifenacin Succinate Drug Product and Services
2.4.4 Aurobindo Pharma Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Glenmark Pharmaceuticals
2.5.1 Glenmark Pharmaceuticals Details
2.5.2 Glenmark Pharmaceuticals Major Business
2.5.3 Glenmark Pharmaceuticals Solifenacin Succinate Drug Product and Services
2.5.4 Glenmark Pharmaceuticals Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Qilu Pharmaceutical
2.6.1 Qilu Pharmaceutical Details
2.6.2 Qilu Pharmaceutical Major Business
2.6.3 Qilu Pharmaceutical Solifenacin Succinate Drug Product and Services
2.6.4 Qilu Pharmaceutical Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business
2.7.3 Cipla Solifenacin Succinate Drug Product and Services
2.7.4 Cipla Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Jiangxi Boya Seehot Pharmaceutical
2.8.1 Jiangxi Boya Seehot Pharmaceutical Details
2.8.2 Jiangxi Boya Seehot Pharmaceutical Major Business
2.8.3 Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Product and Services
2.8.4 Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Solifenacin Succinate Drug Breakdown Data by Manufacturer
3.1 Global Solifenacin Succinate Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Solifenacin Succinate Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Solifenacin Succinate Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Solifenacin Succinate Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Solifenacin Succinate Drug Manufacturer Market Share in 2021
3.5 Global Solifenacin Succinate Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Solifenacin Succinate Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Solifenacin Succinate Drug Market Size by Region
4.1.1 Global Solifenacin Succinate Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Solifenacin Succinate Drug Revenue by Region (2017-2028)
4.2 North America Solifenacin Succinate Drug Revenue (2017-2028)
4.3 Europe Solifenacin Succinate Drug Revenue (2017-2028)
4.4 Asia-Pacific Solifenacin Succinate Drug Revenue (2017-2028)
4.5 South America Solifenacin Succinate Drug Revenue (2017-2028)
4.6 Middle East and Africa Solifenacin Succinate Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Solifenacin Succinate Drug Sales in Volume by Type (2017-2028)
5.2 Global Solifenacin Succinate Drug Revenue by Type (2017-2028)
5.3 Global Solifenacin Succinate Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Solifenacin Succinate Drug Sales in Volume by Application (2017-2028)
6.2 Global Solifenacin Succinate Drug Revenue by Application (2017-2028)
6.3 Global Solifenacin Succinate Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Solifenacin Succinate Drug Sales by Type (2017-2028)
7.2 North America Solifenacin Succinate Drug Sales by Application (2017-2028)
7.3 North America Solifenacin Succinate Drug Market Size by Country
7.3.1 North America Solifenacin Succinate Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Solifenacin Succinate Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Solifenacin Succinate Drug Sales by Type (2017-2028)
8.2 Europe Solifenacin Succinate Drug Sales by Application (2017-2028)
8.3 Europe Solifenacin Succinate Drug Market Size by Country
8.3.1 Europe Solifenacin Succinate Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Solifenacin Succinate Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Solifenacin Succinate Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Solifenacin Succinate Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Solifenacin Succinate Drug Market Size by Region
9.3.1 Asia-Pacific Solifenacin Succinate Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Solifenacin Succinate Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Solifenacin Succinate Drug Sales by Type (2017-2028)
10.2 South America Solifenacin Succinate Drug Sales by Application (2017-2028)
10.3 South America Solifenacin Succinate Drug Market Size by Country
10.3.1 South America Solifenacin Succinate Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Solifenacin Succinate Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Solifenacin Succinate Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Solifenacin Succinate Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Solifenacin Succinate Drug Market Size by Country
11.3.1 Middle East & Africa Solifenacin Succinate Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Solifenacin Succinate Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Solifenacin Succinate Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Solifenacin Succinate Drug
12.3 Solifenacin Succinate Drug Production Process
12.4 Solifenacin Succinate Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Solifenacin Succinate Drug Typical Distributors
13.3 Solifenacin Succinate Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Solifenacin Succinate Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Solifenacin Succinate Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Astellas Pharma Major Business
Table 5. Astellas Pharma Solifenacin Succinate Drug Product and Services
Table 6. Astellas Pharma Solifenacin Succinate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Major Business
Table 9. Teva Solifenacin Succinate Drug Product and Services
Table 10. Teva Solifenacin Succinate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Ajanta Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Ajanta Pharma Major Business
Table 13. Ajanta Pharma Solifenacin Succinate Drug Product and Services
Table 14. Ajanta Pharma Solifenacin Succinate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Aurobindo Pharma Major Business
Table 17. Aurobindo Pharma Solifenacin Succinate Drug Product and Services
Table 18. Aurobindo Pharma Solifenacin Succinate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Glenmark Pharmaceuticals Major Business
Table 21. Glenmark Pharmaceuticals Solifenacin Succinate Drug Product and Services
Table 22. Glenmark Pharmaceuticals Solifenacin Succinate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Qilu Pharmaceutical Major Business
Table 25. Qilu Pharmaceutical Solifenacin Succinate Drug Product and Services
Table 26. Qilu Pharmaceutical Solifenacin Succinate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Cipla Basic Information, Manufacturing Base and Competitors
Table 28. Cipla Major Business
Table 29. Cipla Solifenacin Succinate Drug Product and Services
Table 30. Cipla Solifenacin Succinate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Jiangxi Boya Seehot Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Jiangxi Boya Seehot Pharmaceutical Major Business
Table 33. Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Product and Services
Table 34. Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Solifenacin Succinate Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Solifenacin Succinate Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Solifenacin Succinate Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Solifenacin Succinate Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Solifenacin Succinate Drug Production Site of Key Manufacturer
Table 40. Solifenacin Succinate Drug New Entrant and Capacity Expansion Plans
Table 41. Solifenacin Succinate Drug Mergers & Acquisitions in the Past Five Years
Table 42. Global Solifenacin Succinate Drug Sales by Region (2017-2022) & (K Units)
Table 43. Global Solifenacin Succinate Drug Sales by Region (2023-2028) & (K Units)
Table 44. Global Solifenacin Succinate Drug Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Solifenacin Succinate Drug Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Solifenacin Succinate Drug Sales by Type (2017-2022) & (K Units)
Table 47. Global Solifenacin Succinate Drug Sales by Type (2023-2028) & (K Units)
Table 48. Global Solifenacin Succinate Drug Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Solifenacin Succinate Drug Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Solifenacin Succinate Drug Price by Type (2017-2022) & (USD/Unit)
Table 51. Global Solifenacin Succinate Drug Price by Type (2023-2028) & (USD/Unit)
Table 52. Global Solifenacin Succinate Drug Sales by Application (2017-2022) & (K Units)
Table 53. Global Solifenacin Succinate Drug Sales by Application (2023-2028) & (K Units)
Table 54. Global Solifenacin Succinate Drug Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Solifenacin Succinate Drug Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Solifenacin Succinate Drug Price by Application (2017-2022) & (USD/Unit)
Table 57. Global Solifenacin Succinate Drug Price by Application (2023-2028) & (USD/Unit)
Table 58. North America Solifenacin Succinate Drug Sales by Country (2017-2022) & (K Units)
Table 59. North America Solifenacin Succinate Drug Sales by Country (2023-2028) & (K Units)
Table 60. North America Solifenacin Succinate Drug Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Solifenacin Succinate Drug Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Solifenacin Succinate Drug Sales by Type (2017-2022) & (K Units)
Table 63. North America Solifenacin Succinate Drug Sales by Type (2023-2028) & (K Units)
Table 64. North America Solifenacin Succinate Drug Sales by Application (2017-2022) & (K Units)
Table 65. North America Solifenacin Succinate Drug Sales by Application (2023-2028) & (K Units)
Table 66. Europe Solifenacin Succinate Drug Sales by Country (2017-2022) & (K Units)
Table 67. Europe Solifenacin Succinate Drug Sales by Country (2023-2028) & (K Units)
Table 68. Europe Solifenacin Succinate Drug Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Solifenacin Succinate Drug Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Solifenacin Succinate Drug Sales by Type (2017-2022) & (K Units)
Table 71. Europe Solifenacin Succinate Drug Sales by Type (2023-2028) & (K Units)
Table 72. Europe Solifenacin Succinate Drug Sales by Application (2017-2022) & (K Units)
Table 73. Europe Solifenacin Succinate Drug Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Solifenacin Succinate Drug Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Solifenacin Succinate Drug Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Solifenacin Succinate Drug Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Solifenacin Succinate Drug Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Solifenacin Succinate Drug Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Solifenacin Succinate Drug Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Solifenacin Succinate Drug Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Solifenacin Succinate Drug Sales by Application (2023-2028) & (K Units)
Table 82. South America Solifenacin Succinate Drug Sales by Country (2017-2022) & (K Units)
Table 83. South America Solifenacin Succinate Drug Sales by Country (2023-2028) & (K Units)
Table 84. South America Solifenacin Succinate Drug Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Solifenacin Succinate Drug Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Solifenacin Succinate Drug Sales by Type (2017-2022) & (K Units)
Table 87. South America Solifenacin Succinate Drug Sales by Type (2023-2028) & (K Units)
Table 88. South America Solifenacin Succinate Drug Sales by Application (2017-2022) & (K Units)
Table 89. South America Solifenacin Succinate Drug Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Solifenacin Succinate Drug Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Solifenacin Succinate Drug Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Solifenacin Succinate Drug Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Solifenacin Succinate Drug Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Solifenacin Succinate Drug Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Solifenacin Succinate Drug Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Solifenacin Succinate Drug Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Solifenacin Succinate Drug Sales by Application (2023-2028) & (K Units)
Table 98. Solifenacin Succinate Drug Raw Material
Table 99. Key Manufacturers of Solifenacin Succinate Drug Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Solifenacin Succinate Drug Typical Distributors
Table 103. Solifenacin Succinate Drug Typical Customers
List of Figures
Figure 1. Solifenacin Succinate Drug Picture
Figure 2. Global Solifenacin Succinate Drug Revenue Market Share by Type in 2021
Figure 3. 5 mg Tablet
Figure 4. 10 mg Tablet
Figure 5. Global Solifenacin Succinate Drug Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Drug store
Figure 8. Global Solifenacin Succinate Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Solifenacin Succinate Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Solifenacin Succinate Drug Sales (2017-2028) & (K Units)
Figure 11. Global Solifenacin Succinate Drug Price (2017-2028) & (USD/Unit)
Figure 12. Global Solifenacin Succinate Drug Production Capacity (2017-2028) & (K Units)
Figure 13. Global Solifenacin Succinate Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Solifenacin Succinate Drug Market Drivers
Figure 15. Solifenacin Succinate Drug Market Restraints
Figure 16. Solifenacin Succinate Drug Market Trends
Figure 17. Global Solifenacin Succinate Drug Sales Market Share by Manufacturer in 2021
Figure 18. Global Solifenacin Succinate Drug Revenue Market Share by Manufacturer in 2021
Figure 19. Solifenacin Succinate Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Solifenacin Succinate Drug Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Solifenacin Succinate Drug Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Solifenacin Succinate Drug Sales Market Share by Region (2017-2028)
Figure 23. Global Solifenacin Succinate Drug Revenue Market Share by Region (2017-2028)
Figure 24. North America Solifenacin Succinate Drug Revenue (2017-2028) & (USD Million)
Figure 25. Europe Solifenacin Succinate Drug Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Solifenacin Succinate Drug Revenue (2017-2028) & (USD Million)
Figure 27. South America Solifenacin Succinate Drug Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Solifenacin Succinate Drug Revenue (2017-2028) & (USD Million)
Figure 29. Global Solifenacin Succinate Drug Sales Market Share by Type (2017-2028)
Figure 30. Global Solifenacin Succinate Drug Revenue Market Share by Type (2017-2028)
Figure 31. Global Solifenacin Succinate Drug Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Solifenacin Succinate Drug Sales Market Share by Application (2017-2028)
Figure 33. Global Solifenacin Succinate Drug Revenue Market Share by Application (2017-2028)
Figure 34. Global Solifenacin Succinate Drug Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Solifenacin Succinate Drug Sales Market Share by Type (2017-2028)
Figure 36. North America Solifenacin Succinate Drug Sales Market Share by Application (2017-2028)
Figure 37. North America Solifenacin Succinate Drug Sales Market Share by Country (2017-2028)
Figure 38. North America Solifenacin Succinate Drug Revenue Market Share by Country (2017-2028)
Figure 39. United States Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Solifenacin Succinate Drug Sales Market Share by Type (2017-2028)
Figure 43. Europe Solifenacin Succinate Drug Sales Market Share by Application (2017-2028)
Figure 44. Europe Solifenacin Succinate Drug Sales Market Share by Country (2017-2028)
Figure 45. Europe Solifenacin Succinate Drug Revenue Market Share by Country (2017-2028)
Figure 46. Germany Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Solifenacin Succinate Drug Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Solifenacin Succinate Drug Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Solifenacin Succinate Drug Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Solifenacin Succinate Drug Revenue Market Share by Region (2017-2028)
Figure 55. China Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Solifenacin Succinate Drug Sales Market Share by Type (2017-2028)
Figure 62. South America Solifenacin Succinate Drug Sales Market Share by Application (2017-2028)
Figure 63. South America Solifenacin Succinate Drug Sales Market Share by Country (2017-2028)
Figure 64. South America Solifenacin Succinate Drug Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Solifenacin Succinate Drug Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Solifenacin Succinate Drug Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Solifenacin Succinate Drug Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Solifenacin Succinate Drug Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Solifenacin Succinate Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Solifenacin Succinate Drug in 2021
Figure 76. Manufacturing Process Analysis of Solifenacin Succinate Drug
Figure 77. Solifenacin Succinate Drug Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のコハク酸ジエチルヘキシル市場2022年：市場規模予測（～2028年）
  • 世界のサクシニルコハク酸ジメチル（DMSS）市場2022年：市場規模予測（～2028年）
  • 世界のオクテニルコハク酸デンプンナトリウム（SSOS）市場2022年：市場規模予測（～2028年）
  • 世界のアリピプラゾール薬市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用空カプセル市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19636 )"世界のソリフェナシンコハク酸塩製剤市場2022年：市場規模予測（～2028年）" (英文：Global Solifenacin Succinate Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。